IS5919A - Ný makrólíð sýklalyf - Google Patents

Ný makrólíð sýklalyf

Info

Publication number: IS5919A
Authority: IS; Iceland
Prior art keywords: macrolide antibiotics; new macrolide; new; antibiotics; macrolide
Prior art date: 1998-11-03

Application number

IS5919A

Other languages

English (en)

Inventor

Kaneko Takushi

Original Assignee

Pfizer Products Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-03

Filing date

2001-04-17

Publication date

2001-04-17

2001-04-17 Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.

2001-04-17 Publication of IS5919A publication Critical patent/IS5919A/is

Links

239000003120 macrolide antibiotic agent Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Urology & Nephrology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Cardiology (AREA)
Pulmonology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Heart & Thoracic Surgery (AREA)
Tropical Medicine & Parasitology (AREA)
Vascular Medicine (AREA)
Ophthalmology & Optometry (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

IS5919A 1998-11-03 2001-04-17 Ný makrólíð sýklalyf IS5919A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10683698P	1998-11-03	1998-11-03
PCT/IB1999/001701 WO2000026224A2 (en)	1998-11-03	1999-10-18	Novel macrolide antibiotics

Publications (1)

Publication Number	Publication Date
IS5919A true IS5919A (is)	2001-04-17

Family

ID=22313524

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5919A IS5919A (is)	1998-11-03	2001-04-17	Ný makrólíð sýklalyf

Country Status (34)

Country	Link
US (3)	US20020040007A1 (is)
EP (1)	EP1124837A2 (is)
JP (1)	JP4043191B2 (is)
KR (1)	KR20010083944A (is)
CN (1)	CN1376160A (is)
AP (1)	AP2001002131A0 (is)
AU (1)	AU5995299A (is)
BG (1)	BG105543A (is)
BR (1)	BR9914998A (is)
CA (1)	CA2349338C (is)
CO (1)	CO5140110A1 (is)
CZ (1)	CZ20011512A3 (is)
EA (1)	EA200100396A1 (is)
EE (1)	EE200100245A (is)
GT (1)	GT199900192A (is)
HK (1)	HK1049010A1 (is)
HR (1)	HRP20010306A2 (is)
HU (1)	HUP0104192A3 (is)
ID (1)	ID28286A (is)
IL (1)	IL142628A0 (is)
IS (1)	IS5919A (is)
MA (1)	MA26703A1 (is)
NO (1)	NO20012155L (is)
OA (1)	OA11670A (is)
PA (1)	PA8485101A1 (is)
PE (1)	PE20001289A1 (is)
PL (1)	PL348114A1 (is)
SK (1)	SK5812001A3 (is)
SV (1)	SV1999000188A (is)
TN (1)	TNSN99205A1 (is)
TR (4)	TR200200436T2 (is)
UY (1)	UY25780A1 (is)
WO (1)	WO2000026224A2 (is)
ZA (1)	ZA200103289B (is)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AP9801420A0 (en) *	1998-01-02	1998-12-31	Pfizer Prod Inc	Novel macrolides.
CZ20011512A3 (cs)	1998-11-03	2001-09-12	Pfizer Products Inc.	Nová makrolidová antibiotika
AP2001002222A0 (en)	1999-01-27	2001-09-30	Pfizer Prod Inc	Ketolide antibiotics.
US6451768B1 (en)	1999-04-16	2002-09-17	Kosan Biosciences, Inc.	Macrolide antiinfective agents
US6514944B2 (en)	1999-04-16	2003-02-04	Kosan Biosciences, Inc.	Macrolide antiinfective agents
US6590083B1 (en)	1999-04-16	2003-07-08	Ortho-Mcneil Pharmaceutical, Inc.	Ketolide antibacterials
US6939861B2 (en)	1999-04-16	2005-09-06	Kosan Biosciences, Inc.	Amido macrolides
AU775637B2 (en)	1999-04-16	2004-08-12	Kosan Biosciences, Inc.	Macrolide antiinfective agents
JP2002542197A (ja)	1999-04-16	2002-12-10	オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド	ケトライド抗菌剤
TR200103395T2 (tr)	1999-05-24	2002-04-22	Pfizer Products Inc.	13-metil eritromisin türevleri.
EP1114826A3 (en) *	1999-12-29	2001-10-31	Pfizer Products Inc.	Novel antibacterial and prokinetic macrolides
EP1146051A3 (en) *	2000-04-10	2001-10-31	Pfizer Products Inc.	Erythromycin A derivatives
DE60104240T2 (de) *	2000-06-30	2005-08-04	Pfizer Products Inc., Groton	Makrolid-Antibiotika
BRPI0513903A (pt) *	2004-07-28	2008-05-20	Ranbaxy Lab Ltd	derivados de cetolìdeos úteis como agentes antimicrobianos, seus processos de preparação e composições farmacêuticas compreendendo os mesmos
EP1807439A2 (en) *	2004-10-25	2007-07-18	Ranbaxy Laboratories Limited	Ketolide derivatives as antibacterial agents
EA011281B1 (ru) *	2004-12-21	2009-02-27	Пфайзер Продактс Инк.	Макролиды
WO2007060618A2 (en) *	2005-11-23	2007-05-31	Ranbaxy Laboratories Limited	Macrolides derivatives as antibacterial agents
WO2007060518A2 (en) *	2005-11-23	2007-05-31	Ranbaxy Laboratories Limited	Ketolide derivatives as antibacterial agents
US7801502B2 (en) *	2006-12-18	2010-09-21	Aai Corporation	Method for implementing continuous radio frequency (RF) alignment in advanced electronic warfare (EW) signal stimulation systems
US8409628B2 (en)	2010-02-04	2013-04-02	Penguin IP Holdings, Inc.	Methods and compositions for oxygenation of skin to treat skin disorders
WO2011123619A2 (en)	2010-03-31	2011-10-06	Penguin Ip Holdings Inc.	Permeable mixtures, methods and compositions for the skin
AU2014262127B2 (en) *	2013-05-01	2019-05-02	Neoculi Pty Ltd	Methods for treating bacterial infections
RU2537143C1 (ru) *	2013-11-08	2014-12-27	Государственное научное учреждение Ставропольский научно-исследовательский институт животноводства и кормопроизводства РАСХН	Препарат для лечения и профилактики мастита у коров
WO2018080072A2 (ko) *	2016-10-27	2018-05-03	한국생명공학연구원	신규한 매크로라이드계 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 말라리아의 예방 또는 치료용 약학적 조성물

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI8110592A8 (en) *	1981-03-06	1996-06-30	Pliva Pharm & Chem Works	Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) *	1982-07-19	1984-10-02	Pfizer Inc.	N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
IL99995A (en) *	1990-11-21	1997-11-20	Roussel Uclaf	Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
FR2697524B1 (fr) *	1992-11-05	1994-12-23	Roussel Uclaf	Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en)	1992-11-05	1996-06-18	Roussel Uclaf	Erythromycin derivatives
US5332807A (en)	1993-04-14	1994-07-26	Merck & Co., Inc.	Process of producing 8A- and 9A-azalide antibiotics
FR2702480B1 (fr) *	1993-03-09	1995-04-28	Roussel Uclaf	Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
HRP931480B1 (en) *	1993-12-08	1997-08-31	Sour Pliva	9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A
HRP950145A2 (en) *	1995-03-27	1997-08-31	Sour Pliva	New compounds of the secomacrolide and secoazalide class and a process for the preparation thereof
HN1996000101A (es)	1996-02-28	1997-06-26	Inc Pfizer	Terapia combinada para la osteoporosis
CA2253338C (en) *	1996-05-07	2007-05-08	Abbott Laboratories	6-o-substituted erythromycins and method for making them
WO1998001546A2 (en)	1996-07-05	1998-01-15	Biotica Technology Limited	Polyketides and their synthesis
ATE296831T1 (de) *	1996-09-04	2005-06-15	Abbott Lab	6-0-substituierte ketoliden mit antibakteriellen wirkung
UA51730C2 (uk) *	1996-09-04	2002-12-16	Ебботт Лабораторіз	6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
HRP960497B1 (en)	1996-10-28	2003-08-31	Pliva Pharm & Chem Works	9-n-ethenyl derivatives of 9(s)-erythromycylamine
HN1998000074A (es)	1997-06-11	1999-01-08	Pfizer Prod Inc	Derivados de macrolidos c-4 sustituidos
US6407074B1 (en) *	1997-06-11	2002-06-18	Pfizer Inc	C-4″-substituted macrolide derivatives
EP0895999A1 (en) *	1997-08-06	1999-02-10	Pfizer Products Inc.	C-4" substituted macrolide antibiotics
US6339063B1 (en)	1997-09-10	2002-01-15	Merck & Co., Inc.	9a-azalides as veterinary antimicrobial agents
NZ503897A (en)	1997-10-16	2002-10-25	Pliva Pharm & Chem Works	3,6-hemiketals from the class of 9a-azalides
DK0941998T3 (da)	1998-03-03	2004-09-20	Pfizer Prod Inc	3,6-ketalmakrolidantibiotika
CZ20011512A3 (cs)	1998-11-03	2001-09-12	Pfizer Products Inc.	Nová makrolidová antibiotika
TR200103395T2 (tr)	1999-05-24	2002-04-22	Pfizer Products Inc.	13-metil eritromisin türevleri.
EP1114826A3 (en)	1999-12-29	2001-10-31	Pfizer Products Inc.	Novel antibacterial and prokinetic macrolides
EP1122261A3 (en)	2000-01-31	2001-09-26	Pfizer Products Inc.	13 and 14-membered antibacterial macrolides
DE60104240T2 (de)	2000-06-30	2005-08-04	Pfizer Products Inc., Groton	Makrolid-Antibiotika
JP4509553B2 (ja)	2001-07-03	2010-07-21	ノバルティスバクシンズアンドダイアグノスティックス，インコーポレーテッド	抗菌活性を有するｃ１２修飾エリスロマイシンマクロライドおよびケトライド

1999
- 1999-10-18 CZ CZ20011512A patent/CZ20011512A3/cs unknown
- 1999-10-18 CA CA002349338A patent/CA2349338C/en not_active Expired - Fee Related
- 1999-10-18 TR TR2002/00436T patent/TR200200436T2/xx unknown
- 1999-10-18 HR HR20010306A patent/HRP20010306A2/hr not_active Application Discontinuation
- 1999-10-18 TR TR2001/01241T patent/TR200101241T2/xx unknown
- 1999-10-18 AU AU59952/99A patent/AU5995299A/en not_active Abandoned
- 1999-10-18 OA OA1200100102A patent/OA11670A/en unknown
- 1999-10-18 EA EA200100396A patent/EA200100396A1/ru unknown
- 1999-10-18 BR BR9914998-2A patent/BR9914998A/pt not_active IP Right Cessation
- 1999-10-18 TR TR2002/00435T patent/TR200200435T2/xx unknown
- 1999-10-18 TR TR2002/00434T patent/TR200200434T2/xx unknown
- 1999-10-18 SK SK581-2001A patent/SK5812001A3/sk unknown
- 1999-10-18 HK HK03101144.0A patent/HK1049010A1/zh unknown
- 1999-10-18 HU HU0104192A patent/HUP0104192A3/hu unknown
- 1999-10-18 EE EEP200100245A patent/EE200100245A/xx unknown
- 1999-10-18 ID IDW20010956D patent/ID28286A/id unknown
- 1999-10-18 EP EP99971424A patent/EP1124837A2/en not_active Withdrawn
- 1999-10-18 CN CN99812941A patent/CN1376160A/zh active Pending
- 1999-10-18 JP JP2000579612A patent/JP4043191B2/ja not_active Expired - Fee Related
- 1999-10-18 WO PCT/IB1999/001701 patent/WO2000026224A2/en not_active Ceased
- 1999-10-18 PL PL99348114A patent/PL348114A1/xx not_active Application Discontinuation
- 1999-10-18 IL IL14262899A patent/IL142628A0/xx unknown
- 1999-10-18 AP APAP/P/2001/002131A patent/AP2001002131A0/en unknown
- 1999-10-18 KR KR1020017005535A patent/KR20010083944A/ko not_active Ceased
- 1999-10-29 SV SV1999000188A patent/SV1999000188A/es not_active Application Discontinuation
- 1999-10-29 PE PE1999001084A patent/PE20001289A1/es not_active Application Discontinuation
- 1999-10-29 UY UY25780A patent/UY25780A1/es unknown
- 1999-11-02 TN TNTNSN99205A patent/TNSN99205A1/fr unknown
- 1999-11-02 PA PA19998485101A patent/PA8485101A1/es unknown
- 1999-11-02 MA MA25832A patent/MA26703A1/fr unknown
- 1999-11-03 CO CO99069359A patent/CO5140110A1/es unknown
- 1999-11-03 GT GT199900192A patent/GT199900192A/es unknown
2001
- 2001-04-17 IS IS5919A patent/IS5919A/is unknown
- 2001-04-23 ZA ZA200103289A patent/ZA200103289B/xx unknown
- 2001-05-02 NO NO20012155A patent/NO20012155L/no not_active Application Discontinuation
- 2001-05-29 BG BG105543A patent/BG105543A/xx unknown
- 2001-10-01 US US09/969,486 patent/US20020040007A1/en not_active Abandoned
2002
- 2002-07-24 US US10/206,652 patent/US6835716B2/en not_active Expired - Fee Related
2004
- 2004-07-21 US US10/896,293 patent/US7071170B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
SV1999000188A (es)	2000-10-16
CZ20011512A3 (cs)	2001-09-12
TR200200435T2 (tr)	2002-07-22
PA8485101A1 (es)	2002-08-26
BG105543A (en)	2001-12-29
MA26703A1 (fr)	2004-12-20
US20030013665A1 (en)	2003-01-16
SK5812001A3 (en)	2001-12-03
JP2002528553A (ja)	2002-09-03
NO20012155L (no)	2001-07-02
CA2349338C (en)	2005-12-06
US7071170B2 (en)	2006-07-04
HUP0104192A3 (en)	2003-12-29
HRP20010306A2 (en)	2002-06-30
ID28286A (id)	2001-05-10
EA200100396A1 (ru)	2001-10-22
CA2349338A1 (en)	2000-05-11
HK1049010A1 (zh)	2003-04-25
US20020040007A1 (en)	2002-04-04
US6835716B2 (en)	2004-12-28
UY25780A1 (es)	2001-08-27
OA11670A (en)	2005-01-12
BR9914998A (pt)	2001-07-10
AP2001002131A0 (en)	2001-06-30
HUP0104192A2 (hu)	2002-02-28
WO2000026224A3 (en)	2000-11-16
PL348114A1 (en)	2002-05-06
JP4043191B2 (ja)	2008-02-06
CO5140110A1 (es)	2002-03-22
IL142628A0 (en)	2002-03-10
GT199900192A (es)	2001-04-26
EP1124837A2 (en)	2001-08-22
WO2000026224A2 (en)	2000-05-11
KR20010083944A (ko)	2001-09-03
TNSN99205A1 (fr)	2005-11-10
PE20001289A1 (es)	2000-11-22
EE200100245A (et)	2002-10-15
US20050004047A1 (en)	2005-01-06
TR200200434T2 (tr)	2002-09-23
AU5995299A (en)	2000-05-22
ZA200103289B (en)	2002-08-28
TR200101241T2 (tr)	2001-09-21
CN1376160A (zh)	2002-10-23
NO20012155D0 (no)	2001-05-02
TR200200436T2 (tr)	2002-06-21

Publication	Publication Date	Title
IS5528A (is)	2000-06-09	Ný makrólíð
DE69930818D1 (de)	2006-05-24	Neuartige antibiotika
DE69919769D1 (de)	2004-10-07	3,6-Ketal-Makrolidantibiotika
IS5919A (is)	2001-04-17	Ný makrólíð sýklalyf
DE60124594D1 (de)	2006-12-28	Makrolidantibiotika
ATE256694T1 (de)	2004-01-15	Ketolid-antibiotika
ATE310742T1 (de)	2005-12-15	C-4ß-SUBSTITUTIERTE MACROLID-DERIVATE
DE69838651D1 (de)	2007-12-13	Erythromycinderivate
IS5251A (is)	1999-11-16	9-oxím erýþrómýsín afleiður
PT1119430E (pt)	2004-03-31	Fresa
DE69902762D1 (de)	2002-10-10	Riser-spannanordnung
ID27775A (id)	2001-04-26	Antibiotik-antibiotik nokatiasin
DK1027362T3 (da)	2005-10-31	2-halogen-6-O-substituerede ketolidderivater
PT1076660E (pt)	2002-11-29	(4-bromopirazol-3-il)-benzazolos substituidos
NO20016200L (no)	2002-02-12	Antibiotika
PT984975E (pt)	2003-09-30	Derivados de eritromicina multiciclicos
FI971952A0 (fi)	1997-05-07	Antibiotiskt aemne
ID26522A (id)	2001-01-11	Antibiotik turunan steroid
BR1100453A (pt)	2006-05-09	derivados de eritromicina
SE9902890D0 (sv)	1999-08-12	Golvrelaterat arrangemang
UA3150S (uk)	1999-11-12	Печиво
UA3149S (uk)	1999-11-12	Печиво